實驗概要
Intended Use
Dynabeads? Streptavidin are ideal for numerous applications, including purification of proteins, nucleic acids purification, protein interaction studies, immunoprecipitation, immunoassays, phage display, biopanning, drug screening and cell isolation.
Guidelines for Use
All Dynabeads? Streptavidin can be used with biotinylated molecules. Some beads are more suitable for particular applications due to their characteristics. Dynabeads? M-280 Streptavidin and Dynabeads? MyOne? Streptavidin T1 are commonly used for protein and nucleic acids applications. Dynabeads? M-270 Streptavidin and Dynabeads? MyOne Streptavidin C1 are preferred for nucleic acid diagnostics, specifically with samples with a high chaotropic salt concentration, immunoassays involving small biotinylated antigens and applications that are not compatible with BSA (these beads are not blocked with BSA). MyOne Dynabeads? offer increased binding capacity and slower sedimentation rate, making them ideal for automated applications and for when larger amounts of biotinylated ligand, or their specific target, need to be isolated.
Description of Materials
Dynabeads? Streptavidin are uniform, superparamagnetic beads with a streptavidin monolayer covalently coupled to the surface. This layer ensures negligible streptavidin leakage while the lack of excess adsorbed streptavidin ensures batch consistency and reproducibility of results. These beads give simple and stable binding of biotinylated molecules such as small molecules, peptides, proteins, antibodies, sugars, lectins, oligonucleotides, DNA/RNA etc.
主要試劑
Dynabeads? Streptavidin Trial Kit
Magnet (Dynal? MPC?) for manual or automated protocols
Mixing device with tilting and rotation
Biotinylated compounds
實驗步驟
1. Immobilization Procedure
1) Resuspend the beads in the original vial by rotation or vortexing.
2) Calculate the amount of beads required based on their binding capacity and transfer the beads to a new tube.
3) Wash Dynabeads? to remove preservatives.
4) Place the tube containing the beads on a magnet for 1-2 mins.
5) Remove the supernatant by aspiration with a pipette while the tube is on the magnet.
6) Remove the tube from the magnet.
7) Add washing buffer along the inside of the tube where the beads are collected and resuspend (same volume of washing buffer as the initial volume of Dynabeads? taken from the vial or larger).
8) Repeat steps 4 to 7 twice, for a total of 3 washes.
2. General Immobilization Protocol
1) Add the biotinylated molecule to the washed Dynabeads? .
2) Incubate for 15-30 min at room temperature with gentle rotation of the tube.
3) Place the tube in a magnet for 2-3 mins and discard the supernatant.
4) Wash the coated beads 3-4 times in washing buffer.
5) Resuspend to desired concentration in a suitable buffer for your downstream use.
3. Release of Immobilized Biotinylated Molecules
The biotin-streptavidin bond is broken by harsh conditions. 5 mins incubation at 65°C or 2 mins at 90°C in 10 mM EDTA pH 8.2 with 95% formamide will typically dissociate >96% of immobilized biotinylated DNA. Alternatively, boi the sample for 5 mins in 0.1% SDS for dissociation. Please note that proteins will be denatured by such treatmen and Dynabeads? Streptavidin can not be re-used. It has also been reported that the biotin-streptavidin interaction can be broken by a short incubation in nonionic aqueous solution at temperature above 70°C.
注意事項
Critical Notes
1. In the protocols we recommend keeping the tube on the magnet for up to 2 mins to ensure that all the beads are collected on the tube wall. For non-viscous samples, separation is often complete in under 1 min, once you can see the beads collected.
2. If you do not need to remove preservatives or change buffers you can omit Washing Procedure.
3. For diluted sample or large sample volumes, increase the incubation time or isolate in smaller batches using the same beads in each batch.
4. Use a mixer to tilt/rotate the tubes so Dynabeads? do not settle at the tube bottom.
5. Avoid air bubbles during pipetting.
6. Free biotin or biotinylated primer in the sample will reduce the binding capacity of the beads. A disposable separation column or a spin column will remove unincorporated biotin. Run the PCR with limiting concentrations of biotinylated primer, or remove free biotinylated primer by ultrafiltration, microdialysis or other clean-up protocols.
10月25日,中國科學院分子植物科學卓越創新中心研究員王四寶團隊等在CellReports上,在線發表了題為ExpressionofmosquitomiRNAsinentomopathogenicfu......
中國科學院武漢病毒研究所/病毒學國家重點實驗室研究員周溪團隊在昆蟲RNAi抗病毒免疫研究方面取得重要進展,揭示依諾沙星(Enoxacin)通過增強昆蟲體內的RNAi抗病毒免疫,對多種病毒顯示出廣譜抗病......
RNAi是一種在真核生物中高度保守的轉錄后基因沉默機制,同時也是一種高效的抗病毒天然免疫機制。當病毒感染宿主細胞后,病毒RNA復制所產生的dsRNA被RNAi通路關鍵蛋白Dicer識別,并切割成病毒來......
2021年6月21日,ArrowheadPharmaceuticals與HorizonTherapeutics聯合宣布,兩家公司就在研RNA干擾(RNAi)療法ARO-XDH達成全球合作和許可協議,用......
(圖片來源于網絡,如有侵權,請聯系刪除)基于RNAi的藥物是合成殺蟲劑的高效替代品。RNA干擾(RNAinterference,RNAi)是由RNA分子引發的特異性阻礙靶標基因表達的自然生物過程,普遍......
Arrowhead是一家臨床階段的生物技術公司,致力于利用RNA干擾(RNAi)抑制致病基因的轉錄后表達,開發治療難治性疾病的創新藥物。近日,該公司宣布,評估RNAi藥物ARO-AAT的II期研究AR......
Arrowhead是一家臨床階段的生物技術公司,致力于利用RNA干擾(RNAi)抑制致病基因的轉錄后表達,開發治療難治性疾病的創新藥物。近日,該公司宣布,評估RNAi藥物ARO-AAT的II期研究AR......
Alnylam制藥公司是RNAi療法開發領域的領軍企業,該公司藥物Onpattro(patisiran)于2018年8月獲美國和歐盟批準,用于遺傳性ATTR(hATTR)淀粉樣變性成人患者第1階段或第......
TheMedicinesCompany(TMC)公司近日在費城舉行的2019年美國心臟協會(AHA)年度科學會議上公布了siRNA降脂藥物inclisiranIII期臨床研究ORION-10的詳細數據......
TheMedicinesCompany(TMC)公司近日公布siRNA降脂藥物inclisiran兩項III期臨床研究(ORION-9,ORION-10)的積極頂線數據。ORION-9研究在雜合子家族......